Study to evaluate the bi-weekly schedule of eribulin for patients with advanced or reccurent breast cancer
Not Applicable
- Conditions
- advanced or reccurent breast cancer
- Registration Number
- JPRN-UMIN000009084
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Systemic infection 2)Dirrea, ileus 3)GI bleeding 4)Sever drug allergy 5)Sever renal and/or liver disfunction 6)Significant interstitial pneumonia or plumonary fibrosis by chest X-P 7)Pleural effusion, peritoneal effusion 8)Uncontrolled hypertension or diabetes mellitus 9)Maintenance therapy with systemic corticosteroids 10)Pregnant women or women with suspected pregnancy 11)Active double cancer 12)Severe psychiatric disorder 13)Active brain metastases 14)Participating in other chemotherapy or study 15) Judeged by the investigator to be unfit for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method